Myers, Greggory
Friedman, Ann
Yu, Lei
Pourmandi, Narges
Kerpet, Claire
Ito, Masaki A. https://orcid.org/0009-0000-4155-7444
Saba, Rilie https://orcid.org/0009-0004-9799-5151
Tang, Vi https://orcid.org/0000-0001-6079-9756
Ozel, Ayse Bilge https://orcid.org/0000-0002-1112-4258
Bergin, Ingrid L. https://orcid.org/0000-0001-5436-4633
Johnson, Craig N.
Ku, Chia-Jui
Wang, Yu
Balbin-Cuesta, Ginette
Lim, Kim-Chew
Lin, Zesen
Drysdale, Claire
McGee, Beth
Kurita, Ryo
Nakamura, Yukio https://orcid.org/0000-0001-6834-4123
Liu, Xiaofang
Siemieniak, David
Singh, Sharon A.
Lyssiotis, Costas A. https://orcid.org/0000-0001-9309-6141
Maillard, Ivan https://orcid.org/0000-0003-1312-6748
Weisman, Lois S.
Engel, James Douglas https://orcid.org/0000-0001-9593-1825
Khoriaty, Rami https://orcid.org/0000-0003-2539-5953
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL148333, R01 HL157062, P01 HL146372, U01 HL117658, F31 HL162544)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U2C DK129445, TL1 DK136046)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI091627)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM007315)
Article History
Received: 3 July 2024
Accepted: 1 April 2025
First Online: 12 April 2025
Competing interests
: I.M. has received research funding from Genentech and Regeneron, and he is a member of Garuda Therapeutic’s scientific advisory board. Other authors declare no competing interests.